SCHEDULE: T. Rowe Price Discloses 11.3% Stake in Fabrinet

T. Rowe Price Associates, Inc. has reported beneficial ownership of 11.3% of Fabrinet's common stock as of December 31, 2025.

Summary

• T. Rowe Price Associates, Inc. filed a Schedule 13G, indicating beneficial ownership in Fabrinet.
• The filing reports that T. Rowe Price Associates, Inc. beneficially owns 4,041,675 shares of Fabrinet's common stock.
• This ownership represents 11.3% of the total class of Fabrinet's common stock.
• T. Rowe Price Associates, Inc. holds sole voting power over 3,842,803 shares.
• T. Rowe Price Associates, Inc. holds sole dispositive power over 4,041,666 shares.
• The securities were acquired and are held in the ordinary course of business.
• The acquisition was not for the purpose of changing or influencing the control of Fabrinet.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine disclosure of institutional ownership without specific positive or negative operational news.

Positives

• T. Rowe Price Associates, Inc., a prominent investment adviser, holds a significant 11.3% stake in Fabrinet, indicating substantial institutional confidence.

Future Outlook

NA

Management Comments

• T. Rowe Price Associates, Inc. certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Fabrinet.
• T. Rowe Price Associates, Inc. expressly denies beneficial ownership of the securities, stating the filing should not be construed as an admission of such.

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased transparency regarding institutional ownership in Fabrinet.
• Management: Awareness of a significant passive institutional holder in the company's common stock.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of a significant passive institutional ownership stake by T. Rowe Price Associates, Inc. in Fabrinet. While the presence of a major institutional investor can be viewed as a positive signal of confidence, the filing itself does not contain new operational or financial information about Fabrinet that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on existing analysis of Fabrinet's fundamentals, rather than this ownership disclosure alone.

Keywords

Fabrinet, T. Rowe Price, Schedule 13G, Common Stock, Institutional Ownership, Investment Adviser, Equity Stake